Results showed while there was a significant increase in IL-22 producing ILC3s for LM disease mice given I3C treatment (LM+Colitis+I3C) compared to their respective disease controls (LM+Colitis+Vehicle), AhRΔRorc mice failed to respond in a similar fashion (Figures 3A–C). This evidence concerns the gene IL22 and colitis.